financetom
Business
financetom
/
Business
/
Tapestry to invest $15 million in recycled leather brand Gen Phoenix
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tapestry to invest $15 million in recycled leather brand Gen Phoenix
Jul 15, 2025 1:17 AM

(Reuters) -Coach and Kate Spade parent Tapestry will invest $15 million in eco-leather producer Gen Phoenix as part of an effort to make more sustainable leather goods, the companies told Reuters.

Tapestry's investment will bring its stake in Gen Phoenix to 9.9%. Tapestry said the partnership will bolster its efforts to attract younger Generation Z consumers - those born from 1997 to 2012 - who have an appetite for sustainable leather goods.

The companies' partnership began in 2022 with the launch of Coach's Gen-Z oriented Coachtopia line, which makes products designed with at least 50% recycled leather fibers from waste that are supplied by Gen Phoenix, according to its website.

Scott Roe, who is both chief financial and chief operating officer at Tapestry, said Coachtopia is a bellwether for younger consumers' spending habits. 

"It's not that Coachtopia is so commercially massive, but it is helping us understand what's important to this really critical demographic," he said.

Roe would not say how much Coachtopia accounts for in Tapestry's total earnings, only that it is "relatively small." Gen Phoenix estimates that its materials have an 80% lower carbon footprint than virgin leather. 

The brands previously collaborated on an uncoated lining material that Coachtopia brought to market in under a year, said Elyse Winer, chief marketing officer at Gen Phoenix. 

As part of the investment, Gen Phoenix, which sources waste materials from European tanneries and factories, will supply recycled leather to Tapestry for three years.

Gen Phoenix CEO John Kennedy said the company is eager to work with all of Tapestry's brands.

Roe said it remains to be seen how the recycled material could be used in other product lines.

"There's a lot of opportunities to redirect a lot of that waste stream," he said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ascend Wellness' Q2 net loss widens
Ascend Wellness' Q2 net loss widens
Aug 7, 2025
Overview * Ascend Wellness ( AAWH ) Q2 revenue flat at $127.3 mln, adjusted EBITDA rises 5.7% * Company fully retires $60 mln term loan via strategic refinancing * Net loss widens to $24.4 mln due to higher G&A expenses Outlook * Company aims for 60 total stores in medium-term * Ascend Wellness ( AAWH ) to expand high-margin product...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
CytomX Therapeutics beats Q2 revenue estimates
CytomX Therapeutics beats Q2 revenue estimates
Aug 7, 2025
Overview * CytomX Q2 2025 revenue of $18.7 mln beats analyst expectations, per LSEG data * Operating expenses decreased due to reduced R&D costs and program de-prioritization * Completed $100 mln stock offering, raising cash position to $158.1 mln * Announced positive interim data for CX-2051 in advanced colorectal cancer Outlook * Company expects CX-2051 Phase 1 data update by...
ICU Medical Q2 revenue, adjusted EPS beats estimates
ICU Medical Q2 revenue, adjusted EPS beats estimates
Aug 7, 2025
Overview * ICU Medical Q2 2025 revenue beats analyst expectations despite year-over-year decline * Adjusted EPS and EBITDA for Q2 2025 exceed analyst estimates, per LSEG data * Company updates fiscal 2025 guidance, narrowing GAAP net loss and EBITDA range Outlook * ICU Medical ( ICUI ) updates FY 2025 GAAP net loss to $(43) mln to $(35) mln *...
Copyright 2023-2026 - www.financetom.com All Rights Reserved